148 related articles for article (PubMed ID: 27966721)
21. Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErbB Receptors.
Olivero-Acosta M; Maldonado-Rojas W; Olivero-Verbel J
Molecules; 2017 Feb; 22(2):. PubMed ID: 28218686
[TBL] [Abstract][Full Text] [Related]
22. Investigating molecular dynamics-guided lead optimization of EGFR inhibitors.
Lavecchia MJ; Puig de la Bellacasa R; Borrell JI; Cavasotto CN
Bioorg Med Chem; 2016 Feb; 24(4):768-78. PubMed ID: 26810832
[TBL] [Abstract][Full Text] [Related]
23. Anchor-based classification and type-C inhibitors for tyrosine kinases.
Hsu KC; Sung TY; Lin CT; Chiu YY; Hsu JT; Hung HC; Sun CM; Barve I; Chen WL; Huang WC; Huang CT; Chen CH; Yang JM
Sci Rep; 2015 Jun; 5():10938. PubMed ID: 26077136
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs.
Chen G; Seukep AJ; Guo M
Mar Drugs; 2020 Oct; 18(11):. PubMed ID: 33143025
[TBL] [Abstract][Full Text] [Related]
25. Blocking the interaction between HIV-1 integrase and human LEDGF/p75: mutational studies, virtual screening and molecular dynamics simulations.
Reddy KK; Singh P; Singh SK
Mol Biosyst; 2014 Mar; 10(3):526-36. PubMed ID: 24389668
[TBL] [Abstract][Full Text] [Related]
26. Computer-Aided Drug Discovery from Marine Compounds: Identification of the Three-Dimensional Structural Features Responsible for Antimalarial Activity.
Fattorusso C; Persico M; Rondinelli F; Orteca N; Di Dato A
Prog Mol Subcell Biol; 2017; 55():105-158. PubMed ID: 28238037
[TBL] [Abstract][Full Text] [Related]
27. Ensemble docking and molecular dynamics identify knoevenagel curcumin derivatives with potent anti-EGFR activity.
Yadav IS; Nandekar PP; Srivastavaa S; Sangamwar A; Chaudhury A; Agarwal SM
Gene; 2014 Apr; 539(1):82-90. PubMed ID: 24491504
[TBL] [Abstract][Full Text] [Related]
28. In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha.
Maruthanila VL; Elancheran R; Roy NK; Bhattacharya A; Kunnumakkara AB; Kabilan S; Kotoky J
Curr Comput Aided Drug Des; 2019; 15(1):89-96. PubMed ID: 30306879
[TBL] [Abstract][Full Text] [Related]
29. Discovery of Non-Peptidic Compounds against Chagas Disease Applying Pharmacophore Guided Molecular Modelling Approaches.
Rampogu S; Lee G; Baek A; Son M; Park C; Zeb A; Yoon SH; Park S; Lee KW
Molecules; 2018 Nov; 23(12):. PubMed ID: 30469538
[TBL] [Abstract][Full Text] [Related]
30. In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2.
Ahmed M; Sadek MM; Abouzid KA; Wang F
J Mol Graph Model; 2013 Jul; 44():220-31. PubMed ID: 23911931
[TBL] [Abstract][Full Text] [Related]
31. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of
Babu TM; Rammohan A; Baki VB; Devi S; Gunasekar D; Rajendra W
Drug Des Devel Ther; 2016; 10():3611-3632. PubMed ID: 27853354
[TBL] [Abstract][Full Text] [Related]
32. Investigation of Marine-Derived Natural Products as Raf Kinase Inhibitory Protein (RKIP)-Binding Ligands.
Parate S; Kumar V; Hong JC; Lee KW
Mar Drugs; 2021 Oct; 19(10):. PubMed ID: 34677480
[TBL] [Abstract][Full Text] [Related]
33. Rational discovery of novel type-III FTF antagonists to competitively suppress TIF-2 coactivation in liver cancer.
Xu L; Chen Z; Shao K; Wang Y; Cui L; Guo N
J Recept Signal Transduct Res; 2019 Aug; 39(4):304-311. PubMed ID: 31755335
[TBL] [Abstract][Full Text] [Related]
34. Identification of Binding Mode and Prospective Structural Features of Novel Nef Protein Inhibitors as Potential Anti-HIV Drugs.
Moonsamy S; Bhakat S; Ramesh M; Soliman ME
Cell Biochem Biophys; 2017 Mar; 75(1):49-64. PubMed ID: 27981421
[TBL] [Abstract][Full Text] [Related]
35. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
[TBL] [Abstract][Full Text] [Related]
36. Molecular modeling study bioactive natural product of khellin analogues as a novel potential pharmacophore of EGFR inhibitors.
Elgazwy AS; Edrees MM; Ismail NS
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1171-81. PubMed ID: 23025406
[TBL] [Abstract][Full Text] [Related]
37. Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation.
Matsuzaki H; Daitoku H; Hatta M; Aoyama H; Yoshimochi K; Fukamizu A
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11278-83. PubMed ID: 16076959
[TBL] [Abstract][Full Text] [Related]
38. Comparative docking of dual conformations in human fatty acid synthase thioesterase domain reveals potential binding cavity for virtual screening of ligands.
John A; Vetrivel U; Subramanian K; Deepa PR
J Biomol Struct Dyn; 2017 May; 35(6):1350-1366. PubMed ID: 27145135
[TBL] [Abstract][Full Text] [Related]
39. Bioprospecting microbial natural product libraries from the marine environment for drug discovery.
Liu X; Ashforth E; Ren B; Song F; Dai H; Liu M; Wang J; Xie Q; Zhang L
J Antibiot (Tokyo); 2010 Aug; 63(8):415-22. PubMed ID: 20606699
[TBL] [Abstract][Full Text] [Related]
40. N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes.
Kaszuba K; Grzybek M; Orłowski A; Danne R; Róg T; Simons K; Coskun Ü; Vattulainen I
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4334-9. PubMed ID: 25805821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
